Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

Expand
titletx.xpt (trial sets)
  • During CT definition/reviews will decide appropriate TXPARM and TXVAL; Treatment duration may be controlled;  For now, we just include good example values based on our experience
  • Assumption: The Trial Sets (TX) domain provides the list of distinct sets of subjects having different experimental factors, treatment factors, inherent characteristics, or distinct sponsor designations as specified in the trial design.
  • Where is TK6 cell type?  is this test system (see below)
    • needs to be allowed to vary down to the well level / result level
  • Do we need both SPDEVID AND DUREFID?
  • What are good values (realistic) for "SET"?
  • Check Essential Data list 

A1:


A2:                                   

24
RowSTUDYIDASSAYIDDOMAINSETCD
SET (what sponsor calls it, more meaningful label for Tables)
TXSEQTXPARMCDTXPARMTXVAL
1123MNvitTX

A1

(table 1, row 1, ST exposure with S9)

ST+S9C01METACTMetabolic Activation  (this is the type of activation used)+S9
2123MNvitTXA1ST+S9C02METACTFLY/N presence of metabolic activation (this indicates that metabolic activation was used)Y
3123MNvitTX

A1

ST+S9C03TRTDMINTreatment Duration Minimum3
4123MNvitTXA1ST+S9C04TRTDTRGTreatment Duration Target3.5
5123MNvitTXA1ST+S9C05TRTDMAXTreatment Duration Maximum4
6123MNvitTX

A1

ST+S9C06TRTDUTreatment Duration UnitHOURS
7123MNvitTXA1ST+S9C07RCVDMINRecovery Duration Minimum23.5
8123MNvitTXA1ST+S9C08RCVDTRGRecovery Duration Target24
9123MNvitTX

A1

ST+S9C09RCVDMAXRecovery Duration Maximum24.5
10123MNvitTXA1ST+S9C010RCVDURecovery Duration UnitHOURS
11123MNvitTXA1ST+S9C011INCBTMPIncubation Temperature37
12123MNvitTX

A1

ST+S9C012INCBTMPUIncubation Temperature UnitC

13123MNvitTXA1ST+S9C013MEDIAComposition of MediaSartorius HEK293
1413123MNvitTXA1ST+S9C014HUMIDAtmospheric Relative Humidity  Percent50
1514123MNvitTX

A1

ST+S9C015ATMCO2Atmospheric CO2 Percent5
1615123MNvitTXA1ST+S9C016SPTOBID

Sponsor defined tobacco identifier

CIG01a
1716123MNvitTXA1ST+S9C017EXPTYP

Exposure Type (See TIG NC workstream minutes 30-Jan here: Nonclinical)

Submerged
17123MNvitTXA1ST+S9C018SAMTYP 

Sample Type

(e.g. TPM, GVP, whole aerosol, whole smoke conditioned media, aqueous extracts, etc., see notes here: Nonclinical)

Total Particulate Matter in DMSO
18123MNvitTXA1ST+S9C06INTRVN

Name of the Intervention Article

can be:  Tobacco ProdA, Bleomycin (positive control) or Cyclophosphamid A (positive control)

Tobacco ProdA
19123MNvitTXA1ST+S9C07ITVTYPE

type of intervention article

choices of values:  product; negative control; positive control

Negative Control
20123MNvitTXA1ST+S9C08ITVCONCConcentration of intervention article0
21123MNvitTXA1ST+S9C09ITVCONCUConcentration Unitug/ml
22123MNvitTXA1ST+S9C010SPDEVIDSponsor defined device identifierPUFFMASTER3K
23123MNvitTXA1ST+S9C011DUREFIDSmoke RegimenMedium Intensity Regimen

123MNvitTXA1ST+S9C011SMKEXSYSSmoke Exposure SystemCambridge filter pad, eluted in DMSO
25123MNvitTX

A2

(table 1, row 2, ST exposure with S9 at concentration 1250)

ST+S9-12501METACTMetabolic Activation  (should there be two parms? Presence, type)?+S9
26123MNvitTXA2ST+S9-12502METACTFLY/N presence of metabolic activation (this indicates that metabolic activation was used)Y
27123MNvitTXA2ST+S9-12503TRTDRTRGTreatment Duration target. (how do we show 3-6 hour range?  start/end, target and tolerance?, one text field not-analyzable)3
28123MNvitTXA2ST+S9-12504TRTDRTOLTreatment Duration Tolerance
29123MNvitTXA2ST+S9-12505TRTDURUTreatment Duration Unit (this is for both TRTDURT, TRTDURTOL)H
30123MNvitTXA2ST+S9-12506INTRVNname of the intervention articleTobacco ProdA
31123MNvitTXA2ST+S9-12507ITVTYPEtype of intervention articleProduct
32123MNvitTXA2ST+S9-12508ITVCONCConcentration of i a 1250
33123MNvitTXA2ST+S9-12509ITVCONCUConcentration Unitug/ml
34123MNvitTXA2ST+S9-125010SPDEVIDSponsor defined device identifierPUFFMASTER2023
35123MNvitTXA2ST+S9-125011DUREFIDSmoke RegimenHigh Intensity Regimen
...








...